Already a KLAS Partner, Sign in to view the full webinar.
To become a KLAS Partner member, and gain access to all webinars and reports, view our membership options.
Providers can purchase this report to gain access to the webinar.
Reports are available for download when the download buttons are green.
Release Date: Friday, December 14, 2012
Oncology has been late to the meaningful use (MU) game, but the momentum is picking up as Stage 2 rules are bearing down. Patient portals are now inevitable for providers. Altos and McKesson are leading the charge for MU, but with pressure to integrate and consolidate, those vendors are also vulnerable to replacement. Varian and Elekta, the two most prevalent vendors in the oncology IT market, have room to up their game in regard to MU.
View All KLAS Reports